Harvard’s president at the time, Derek Bok, said that the university’s decision “was motivated by a desire not to be associated as a shareholder with companies engaged in significant sales of products that create a substantial and unjustified risk of harm to other human beings.” Many other universities, including Columbia, have done the same.